Trans fatty acids enhanced Beta-Amyloid induced oxidative stress in nerve growth factor differentiated PC12 cells

Neurochemical Research

Volumn 37, Issue 4, 2012, Pages 786-794

  Tsai, Shih Jei ^a,b   Liu, Wen Hu ^a   Yin, Mei Chin ^c,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Amyloid; Mitochondrial dysfunction; Neurodegeneration; PC12 cells; Trans fatty acid

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMYLOID BETA PROTEIN; CASPASE 3; CASPASE 8; CATALASE; ELAIDIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LINOELAIDIC ACID; MATRIX METALLOPROTEINASE; NERVE GROWTH FACTOR; NITRIC OXIDE SYNTHASE; NITRITE; NITRITE OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANS FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL DIFFERENTIATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

AMYLOID BETA-PEPTIDES; ANIMALS; CELL DIFFERENTIATION; CYTOTOXINS; DNA FRAGMENTATION; DRUG SYNERGISM; MEMBRANE POTENTIAL, MITOCHONDRIAL; NERVE GROWTH FACTOR; OXIDATIVE STRESS; PC12 CELLS; PEPTIDE FRAGMENTS; RATS; REACTIVE OXYGEN SPECIES; TRANS FATTY ACIDS;

EID: 84862866762     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0673-1     Document Type: Article

References (31)

1. Sultana R, Butterfield DA (2010) Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimers Dis 19:341-353
2. Wirths O, Multhaup G, Bayer TA (2004) A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide-the first step of a fatal cascade. J Neurochem 91: 513-520 (Pubitemid 39431147)
3. Huang X, Moir RD, Tanzi RE et al (2004) Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann NY Acad Sci 1012:153-163 (Pubitemid 38453522)
4. Gamba P, Leonarduzzi G, Tamagno E et al (2011) Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime. Aging Cell 10:403-417
5. de Roos NM, Bots ML, Katan MB (2001) Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol 21:1233-1237 (Pubitemid 34215156)
6. Lovejoy JC, Smith SR, Champagne CM (2002) Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 25:1283-1288 (Pubitemid 41071133)
7. Morris MC Evans DA, Bienias JL et al (2003) Dietary fats and the risk of incident Alzheimer's disease. Arch Neurol 60:194-200 (Pubitemid 36193962)
8. Teixeira AM, Dias VT, Pase CS et al (2012) Could dietary trans fatty acids induce movement disorders? Effects of exercise and its influence on Na(+)K(+)-ATPase and catalase activity in rat striatum. Behav Brain Res 226:504-510
9. Phivilay A, Julien C, Tremblay C et al (2009) High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. Neurosci 159:296-307
10. Zapolska-Downar D, Kosmider A, Naruszewicz ? (2005) Trans fatty acids induce apoptosis in human endothelial cells. J Physiol Pharmacol 56:611-625 (Pubitemid 43127557)
11. Bryk D, Zapolska-Downar D, Malecki M et al (2011) Trans fatty acids induce a proinflammatory response in endothelial cells through ROS-dependent nuclear factor-jB activation. J Physiol Pharmacol 62:229-238
12. Lipman T, Tabakman R, Lazarovici P (2006) Neuroprotective effects of the stable nitroxide compound Tempol on 1-methyl-4- phenylpyridinium ion-induced neurotoxicity in the nerve growth factor-differentiated model of pheochromocytoma PC12 cell. Eur J Pharmacol 549:50-57 (Pubitemid 44468068)
13. Tsai SJ, Lin CY, Mong MC et al (2010) s-Ethyl cysteine and s-propyl cysteine alleviate beta-amyloid induced cytotoxicity in nerve growth factor differentiated PC12 cells. J Agric Food Chem 58:7104-7108
14. Torlinska T, Grochowalska A (2004) Age-related changes of Na+, K+-ATPase, Ca2+-ATPase and Mg2+-ATPase activities in rat brain synaptosomes. J Physiol Pharmacol 55:457-465 (Pubitemid 38901975)
15. Fu W, Luo H, Parthasarathy S et al (1998) Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol Dis 5:229-243 (Pubitemid 28519153)
16. Lowry OH, Rosebrough NJ, Farr AL (1951) Protein determination with the Folin phenol reagent. J Biol Chem 193:265-275
17. Sutherland BA, Shaw OM, Clarkson AN et al (2005) Neuro- protective effects of (-)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: novel mechanisms of action. FASEB J 19:258-260 (Pubitemid 40189274)
18. Butterfield DA, Galvan V, Lange MB et al (2010) In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP. Free Radic Biol Med 48:136-144
19. Wang XQ, Xiao AY, Shelint C et al (2003) Apoptotic insults impair Na+, K+-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress. J Cell Sci 116:2099-2110 (Pubitemid 36622306)
20. Sharifi AM, Eslami H, Larijani B (2009) Involvement of caspase- 8, -9, and -3 in high glucose-induced apoptosis in PC12 cells. Neurosci Lett 459:47-51
21. Marques CA, Keil U, Bonert A et al (2003) Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J Biol Chem 278:28294-28302 (Pubitemid 36900031)
22. Isobe C, Abe T, Terayama Y (2010) Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. J Neurol 257:399-404
23. Boll MC, Alcaraz-Zubeldia M, Montes S et al (2008) Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases. Neurochem Res 33:1717-1723
24. Esposito G, De Filippis D, Maiuri MC et al (2006) Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett 399:91-95
25. Jang JH, Surh YJ (2005) AP-1 mediates beta-amyloid-induced iNOS expression in PC12 cells via the ERK2 and p38 MAPK signaling pathways. Biochem Biophysical Res Comm 331: 1421-1428
26. Aliev G, Palacios HH, Lipsitt AE et al (2009) Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotoxic Res 16:293-305
27. Duval C, Augé N, Frisach MF et al (2002) Mitochondrial oxidative stress is modulated by oleic acid via an epidermal growth factor receptor-dependent activation of glutathione peroxidase. Biochem J 367:889-894 (Pubitemid 35305730)
28. Dorfman SE, Laurent D, Gounarides JS et al (2009) Metabolic implications of dietary trans-fatty acids. Obesity (Silver Spring) 17:1474
29. Asgary S, Nazari B, Sarrafzadegan N et al (2009) Fatty acid composition of commercially available Iranian edible oils. J Res Med Sci 14:211-215
30. Stachowska E, Dołegowska B, Chlubek D (2004) Dietary trans fatty acids and composition of human atheromatous plaques. Eur JNutr 43:313-318 (Pubitemid 39371625)
31. Chajès V, Thiébaut AC, Rotival M et al (2008) Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am J Epidemiol 167: 1312-1320 (Pubitemid 351770558)